Yumanity Therapeutics Inc (YMTX)
13.2300 +1.0500 (+8.62%) 12/17/22 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Fri, Dec 16th, 2022
Results
download Want to compare other data? Select FieldsSymbol | YMTX | AMGN | BMY | GILD | VRTX |
Company | Yumanity Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
Open | 11.4100 | 260.79 | 56.36 | 90.19 | 406.17 |
High | 13.2300 | 264.79 | 56.52 | 91.43 | 413.52 |
Low | 9.8000 | 260.55 | 55.63 | 88.57 | 405.17 |
Last | 13.2300 | 262.23 | 55.83 | 89.88 | 409.56 |
Change | +1.0500 | -1.98 | -0.98 | +0.74 | -2.55 |
% Change | +8.62% | -0.75% | -1.73% | +0.83% | -0.62% |
Volume | 99,628 | 2,721,900 | 9,681,200 | 7,869,600 | 1,687,800 |
20-Day Average Volume | 312,450 | 3,689,035 | 11,814,565 | 6,429,760 | 1,995,645 |
Previous Close | 12.1800 | 264.21 | 56.81 | 89.14 | 412.11 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 1.8773 | 263.79 | 56.81 | 92.01 | 422.76 |
20-Day Raw Stochastic | 59.76% | 38.86% | 22.54% | 21.55% | 32.92% |
20-Day Relative Strength | 52.61% | 37.55% | 46.22% | 46.10% | 38.71% |
Weighted Alpha | -37.50 | -18.64 | +16.11 | +12.91 | -11.03 |
Today's Opinion | 96% Buy | 100% Sell | 40% Buy | 56% Buy | 88% Sell |
Previous Opinion | 64% Buy | 88% Sell | 40% Buy | 56% Buy | 88% Sell |
Last Month's Opinion | 88% Buy | 72% Sell | 100% Buy | 88% Buy | 24% Buy |
Performance | |||||
5-Days | |||||
%Chg | -5.03% since 12/09/22 | +1.14% since 01/02/25 | -1.69% since 01/02/25 | -2.18% since 01/02/25 | +0.94% since 01/02/25 |
Low | 1.4000 on 12/16/22 | 257.05 on 01/06/25 | 55.63 on 01/10/25 | 88.57 on 01/10/25 | 399.00 on 01/06/25 |
High | 2.0900 on 12/13/22 | 265.21 on 01/07/25 | 57.67 on 01/07/25 | 92.34 on 01/03/25 | 413.52 on 01/10/25 |
1-Month | |||||
%Chg | +3.95% since 11/16/22 | -4.90% since 12/10/24 | -3.94% since 12/10/24 | -2.66% since 12/10/24 | -12.71% since 12/10/24 |
Low | 1.4000 on 12/16/22 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 88.57 on 01/10/25 | 377.85 on 12/19/24 |
High | 2.2200 on 12/08/22 | 276.28 on 12/11/24 | 58.54 on 12/18/24 | 94.65 on 12/11/24 | 474.18 on 12/17/24 |
3-Month | |||||
%Chg | +13.86% since 09/16/22 | -18.31% since 10/10/24 | +6.55% since 10/10/24 | +6.15% since 10/10/24 | -13.99% since 10/10/24 |
Low | 1.4000 on 12/16/22 | 253.30 on 12/19/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 | 377.85 on 12/19/24 |
High | 2.2200 on 12/08/22 | 329.17 on 10/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
6-Month | |||||
%Chg | +20.38% since 06/16/22 | -18.48% since 07/10/24 | +35.77% since 07/10/24 | +30.73% since 07/10/24 | -16.69% since 07/10/24 |
Low | 1.4000 on 12/16/22 | 253.30 on 12/19/24 | 39.92 on 07/15/24 | 68.14 on 07/11/24 | 377.85 on 12/19/24 |
High | 2.2200 on 12/08/22 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
Key Statistics | |||||
Market Capitalization, $K | 20,518 | 140,957,296 | 113,233,128 | 112,014,384 | 105,473,568 |
Shares Outstanding, K | 10,856 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
Annual Sales | 8,040,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
Annual Net Income | -39,500,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
Last Quarter Sales | 1,400,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
Last Quarter Net Income | -3,360,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
60-Month Beta | 0.32 | 0.56 | 0.45 | 0.18 | 0.40 |
Per-Share Information | |||||
Most Recent Earnings | -0.31 on 11/14/22 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
Latest Earnings Date | 11/21/22 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | 0.770 on 12/13/24 | N/A |
Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 13.75 | 48.56 | 20.12 | 0.00 |